enGene Therapeutics Inc. Warrants (NASDAQ: ENGNW) last traded at $0.170, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from enGene Therapeutics Inc. Warrants’s own filings and are restated only when a new one is published.
enGene Therapeutics Inc. Warrants trades on NASDAQ under the ticker ENGNW. Its market capitalisation is $11.39 million.
Valuation measures for enGene Therapeutics Inc. Warrants, derived from the latest quote and its most recent SEC filing.
| Market cap | $11.39M |
|---|---|
| Enterprise value | $28.40M |
| P/E ratio | 0.07 |
| Price / book | 0.05 |
Trailing-twelve-month figures tagged in enGene Therapeutics Inc. Warrants's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$130.36M |
| EPS (TTM) | $2.43 |
|---|
| Return on equity | -56.61% |
|---|
| Cash | $41.02M |
|---|
Range and volume for ENGNW over the past 52 weeks.
| 52-week high | $0.250 |
|---|---|
| 52-week low | $0.144 |
| Volume | 0 |
| Previous close | $0.170 |
Dividend history for enGene Therapeutics Inc. Warrants over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
| Payout ratio | 0.00% |
Invest a chosen dollar amount in enGene Therapeutics Inc. Warrants with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ENGNW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.